Beck Bode LLC Buys 3,305 Shares of Alteryx Inc (NYSE:AYX)

Beck Bode LLC increased its stake in Alteryx Inc (NYSE:AYX) by 8.1% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 44,302 shares of the company’s stock after buying an additional 3,305 shares during the quarter. Alteryx makes up 2.1% of Beck Bode LLC’s portfolio, making the stock its 17th biggest position. Beck Bode LLC’s holdings in Alteryx were worth $4,759,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of AYX. Whale Rock Capital Management LLC raised its stake in Alteryx by 175.4% during the second quarter. Whale Rock Capital Management LLC now owns 2,083,414 shares of the company’s stock valued at $227,342,000 after buying an additional 1,326,900 shares during the last quarter. Vanguard Group Inc. boosted its stake in Alteryx by 30.6% in the 2nd quarter. Vanguard Group Inc. now owns 3,990,240 shares of the company’s stock worth $435,414,000 after purchasing an additional 935,331 shares in the last quarter. Brown Capital Management LLC boosted its stake in Alteryx by 15.2% in the 2nd quarter. Brown Capital Management LLC now owns 3,767,890 shares of the company’s stock worth $411,152,000 after purchasing an additional 498,223 shares in the last quarter. Invesco Ltd. grew its position in Alteryx by 162.9% during the 2nd quarter. Invesco Ltd. now owns 584,092 shares of the company’s stock valued at $63,736,000 after purchasing an additional 361,959 shares during the last quarter. Finally, First Trust Advisors LP grew its position in Alteryx by 298.5% during the 3rd quarter. First Trust Advisors LP now owns 461,822 shares of the company’s stock valued at $49,614,000 after purchasing an additional 345,925 shares during the last quarter. Institutional investors own 70.08% of the company’s stock.

Several brokerages have issued reports on AYX. Wedbush set a $126.00 target price on shares of Alteryx and gave the stock a “buy” rating in a report on Friday, November 1st. DA Davidson dropped their target price on shares of Alteryx from $123.00 to $95.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. Needham & Company LLC reiterated a “buy” rating and set a $140.00 price target on shares of Alteryx in a report on Tuesday, November 19th. Rosenblatt Securities initiated coverage on shares of Alteryx in a research report on Wednesday, August 21st. They set a “neutral” rating and a $137.00 price target for the company. Finally, Bank of America reduced their price target on shares of Alteryx from $140.00 to $112.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Seven analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $120.72.

In related news, CRO Robert Scott Jones sold 1,599 shares of the company’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $146.53, for a total transaction of $234,301.47. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Kevin Rubin sold 13,000 shares of the company’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $135.75, for a total value of $1,764,750.00. The disclosure for this sale can be found here. Insiders sold 77,051 shares of company stock worth $8,406,433 in the last 90 days. 19.82% of the stock is currently owned by corporate insiders.

Shares of NYSE AYX traded down $2.74 during trading on Tuesday, reaching $105.09. 933,248 shares of the company traded hands, compared to its average volume of 1,465,516. The firm has a 50 day simple moving average of $99.77 and a 200-day simple moving average of $110.72. The company has a quick ratio of 5.22, a current ratio of 5.22 and a debt-to-equity ratio of 1.69. The stock has a market capitalization of $7.39 billion, a PE ratio of -525.47, a P/E/G ratio of 10.68 and a beta of 1.08. Alteryx Inc has a 52-week low of $48.34 and a 52-week high of $147.79.

Alteryx (NYSE:AYX) last released its quarterly earnings data on Thursday, October 31st. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.15. The firm had revenue of $103.40 million during the quarter, compared to analysts’ expectations of $90.42 million. Alteryx had a negative net margin of 3.31% and a positive return on equity of 1.09%. The firm’s quarterly revenue was up 65.2% on a year-over-year basis. During the same period in the previous year, the company earned $0.08 earnings per share. As a group, research analysts predict that Alteryx Inc will post 0.27 EPS for the current year.

About Alteryx

Alteryx, Inc operates a self-service data analytics software platform that enables organizations to enhance business outcomes and the productivity of their business analysts, data scientists, and citizen data scientists worldwide. Its software platform includes Alteryx Designer, a data profiling, preparation, blending, and analytics product used to create visual workflows or analytic processes; Alteryx Server, a server-based product for scheduling, sharing, and running analytic processes and applications in a Web-based environment; Alteryx Connect, a collaborative data exploration platform for discovering information assets and sharing recommendations across the enterprise; and Alteryx Promote, an analytics model management product for data scientists and analytics teams to build, manage, monitor, and deploy predictive models into real-time production applications.

Further Reading: How to use beta for portfolio diversification

Want to see what other hedge funds are holding AYX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alteryx Inc (NYSE:AYX).

Institutional Ownership by Quarter for Alteryx (NYSE:AYX)

Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.